The University of Chicago Header Logo

Connection

Parth Modi to Humans

Back to Details
This is a "connection" page, showing publications Parth Modi has written about Humans.
Parth Modi
Connection Strength
0.975
Humans
  1. Growth in Newborn Circumcisions Performed by Pediatric Urologists and Advanced Practice Providers Between 2010 and 2021 in the United States. Urology. 2024 Feb; 184:206-211.
    View in: PubMed
    Score: 0.031
  2. Industry Payments to Urologists and Urologic Advanced Practice Providers in 2021. Urology. 2023 Oct; 180:121-129.
    View in: PubMed
    Score: 0.031
  3. Outcomes of Hematuria Evaluation by Advanced Practice Providers and Urologists. Urology. 2023 Aug; 178:67-75.
    View in: PubMed
    Score: 0.030
  4. Increasing Role of the Advanced Practice Provider in Men's Health Clinics: An Analysis of Medicare and Commercial Claims in the United States. Urol Pract. 2023 07; 10(4):320-325.
    View in: PubMed
    Score: 0.030
  5. Characteristics of prostate cancer patients captured by facility-based versus geography-based cancer registries. Urol Oncol. 2023 07; 41(7):324.e1-324.e7.
    View in: PubMed
    Score: 0.030
  6. Novel cryotherapy in non-muscle-invasive bladder cancer. Cancer. 2023 02 01; 129(3):333-334.
    View in: PubMed
    Score: 0.029
  7. Evaluation of Industry Payments to US Advanced Practice Clinicians in 2021. JAMA Netw Open. 2022 Nov 01; 5(11):e2242869.
    View in: PubMed
    Score: 0.029
  8. The Growth of Advanced Practice Providers in Urology Procedural Care: Evidence from Public and Private Health Insurers. Urology. 2022 10; 168:110-115.
    View in: PubMed
    Score: 0.029
  9. Radical Prostatectomy Without Biopsy: Audacious, Imprudent, or Innovative? Eur Urol. 2022 08; 82(2):161-162.
    View in: PubMed
    Score: 0.028
  10. Clinical and pathological features of renal epithelioid angiomyolipoma (PEComa): A single institution series. Urol Oncol. 2022 02; 40(2):18-24.
    View in: PubMed
    Score: 0.027
  11. Association between Industry Payments and Published Position on Use of Devices for the Treatment of Lower Urinary Tract Symptoms. Urology. 2022 01; 159:87-92.
    View in: PubMed
    Score: 0.027
  12. Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees. Urology. 2021 09; 155:77-82.
    View in: PubMed
    Score: 0.026
  13. Assessing Value-based Health Care Initiatives in Urology. Eur Urol. 2021 05; 79(5):586-587.
    View in: PubMed
    Score: 0.026
  14. Medicare Accountable Care Organizations and the Adoption of New Surgical Technology. J Am Coll Surg. 2021 02; 232(2):138-145.e2.
    View in: PubMed
    Score: 0.025
  15. Prostate-specific Antigen to Predict Early Success of Focal Therapy: Focusing on Appropriate Endpoints. Eur Urol. 2020 08; 78(2):161-162.
    View in: PubMed
    Score: 0.025
  16. Episode Payments for Transcatheter and Surgical Aortic Valve Replacement. Circ Cardiovasc Qual Outcomes. 2019 12; 12(12):e005781.
    View in: PubMed
    Score: 0.024
  17. Practice-Level Adoption of Conservative Management for Prostate Cancer. J Oncol Pract. 2019 10; 15(10):e863-e869.
    View in: PubMed
    Score: 0.024
  18. Urologist Practice Structure and Spending for Prostate Cancer Care. Urology. 2019 Aug; 130:65-71.
    View in: PubMed
    Score: 0.023
  19. EDITORIAL COMMENT. Urology. 2019 02; 124:105-106.
    View in: PubMed
    Score: 0.023
  20. Editorial Comment. Urology. 2019 02; 124:228.
    View in: PubMed
    Score: 0.023
  21. Impact of Medicare Office Visit Payment Reform on Urologic Practices. Urology. 2019 04; 126:83-88.
    View in: PubMed
    Score: 0.023
  22. Medicare Accountable Care Organizations and Use of Potentially Low-Value Procedures. Surg Innov. 2019 Apr; 26(2):227-233.
    View in: PubMed
    Score: 0.022
  23. Searching for the value of accountable care organizations in cancer care. Cancer. 2018 11 15; 124(22):4287-4289.
    View in: PubMed
    Score: 0.022
  24. Real-World Impact of Minimally Invasive Versus Open Radical Cystectomy on Perioperative Outcomes and Spending. Urology. 2019 03; 125:86-91.
    View in: PubMed
    Score: 0.022
  25. Tradeoffs in Refining the Diagnosis of Prostate Cancer. Eur Urol. 2018 12; 74(6):729-730.
    View in: PubMed
    Score: 0.022
  26. National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms. Urology. 2018 Oct; 120:96-102.
    View in: PubMed
    Score: 0.022
  27. Engaging telehealth to drive value-based urology. Curr Opin Urol. 2018 07; 28(4):342-347.
    View in: PubMed
    Score: 0.022
  28. Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations. Cancer. 2018 08; 124(16):3364-3371.
    View in: PubMed
    Score: 0.022
  29. The Receipt of Industry Payments is Associated With Prescribing Promoted Alpha-blockers and Overactive Bladder Medications. Urology. 2018 Jul; 117:50-56.
    View in: PubMed
    Score: 0.021
  30. Pediatric hospitalizations for upper urinary tract calculi: Epidemiological and treatment trends in the United States, 2001-2014. J Pediatr Urol. 2018 02; 14(1):13.e1-13.e6.
    View in: PubMed
    Score: 0.020
  31. Utilization of Pelvic Lymph Node Dissection for Patients With Low-Risk Prostate Cancer Treated With Robot-Assisted Radical Prostatectomy. Clin Genitourin Cancer. 2017 12; 15(6):e1001-e1006.
    View in: PubMed
    Score: 0.020
  32. Safety of Robot-Assisted Radical Prostatectomy with Pneumoperitoneum of 20?mm Hg: A Study of 751 Patients. J Endourol. 2015 Oct; 29(10):1148-51.
    View in: PubMed
    Score: 0.018
  33. Medications and surgical interventions for benign prostatic hyperplasia are potential confounders of prostate-specific antigen. Curr Urol Rep. 2010 Jul; 11(4):224-7.
    View in: PubMed
    Score: 0.012
  34. Bladder-Preserving Trimodality Therapy With Capecitabine. Clin Genitourin Cancer. 2024 04; 22(2):476-482.e1.
    View in: PubMed
    Score: 0.008
  35. Using Implementation Science to Improve Patient Care. J Urol. 2023 10; 210(4):577-579.
    View in: PubMed
    Score: 0.008
  36. Association of Medicare Beneficiary and Hospital Accountable Care Organization Alignment With Surgical Cost Savings. JAMA Health Forum. 2022 12 02; 3(12):e224817.
    View in: PubMed
    Score: 0.007
  37. Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case Series. Urology. 2022 09; 167:171-178.
    View in: PubMed
    Score: 0.007
  38. Aortic valve replacement among patients with Alzheimer's disease and related dementias. J Am Geriatr Soc. 2021 12; 69(12):3468-3475.
    View in: PubMed
    Score: 0.007
  39. Testing-Related Health Impact of Transrectal and Transperineal Prostate Biopsy as Assessed by Health Utilities. J Urol. 2021 12; 206(6):1403-1410.
    View in: PubMed
    Score: 0.007
  40. Impact of Advanced Practice Provider Integration into Multispecialty Group Practices on Outcomes Following Major Surgery. Surg Innov. 2022 Feb; 29(1):111-117.
    View in: PubMed
    Score: 0.007
  41. Effects of Advanced Practice Providers on Single-specialty Surgical Practice. Ann Surg. 2023 Jan 01; 277(1):e40-e45.
    View in: PubMed
    Score: 0.007
  42. Adherence and out-of-pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer. Cancer. 2020 12 01; 126(23):5050-5059.
    View in: PubMed
    Score: 0.006
  43. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation. Cancer. 2020 12 01; 126(23):5114-5123.
    View in: PubMed
    Score: 0.006
  44. Reframing Financial Incentives Around Reducing Readmission After Radical Cystectomy. Urology. 2020 08; 142:99-105.
    View in: PubMed
    Score: 0.006
  45. Impact of pathologic lymph node-positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer. Cancer. 2020 07 01; 126(13):2991-3001.
    View in: PubMed
    Score: 0.006
  46. Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care. Clin Genitourin Cancer. 2020 12; 18(6):e643-e650.
    View in: PubMed
    Score: 0.006
  47. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014. Clin Genitourin Cancer. 2020 04; 18(2):e194-e201.
    View in: PubMed
    Score: 0.006
  48. Substitution of Transcatheter for Surgical Aortic Valve Replacement: An Observational Study. Surg Innov. 2019 12; 26(6):766-767.
    View in: PubMed
    Score: 0.006
  49. Accuracy of clinical nodal staging and factors associated with receipt of lymph node dissection at the time of surgery for nonmetastatic renal cell carcinoma. Urol Oncol. 2019 09; 37(9):577.e17-577.e25.
    View in: PubMed
    Score: 0.006
  50. Adoption of Abiraterone and Enzalutamide by Urologists. Urology. 2019 09; 131:176-183.
    View in: PubMed
    Score: 0.006
  51. Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database. Urol Oncol. 2019 01; 37(1):26-32.
    View in: PubMed
    Score: 0.006
  52. Off-Target Effect of Sildenafil on Postsurgical Erectile Dysfunction: Alternate Pathways and Localized Delivery System. J Sex Med. 2016 12; 13(12):1834-1843.
    View in: PubMed
    Score: 0.005
  53. Editorial Comment. J Urol. 2017 01; 197(1):29.
    View in: PubMed
    Score: 0.005
  54. Long-Term Outcomes of Using Hyaluronic Acid-Carboxymethylcellulose Adhesion Barrier Film on the Neurovascular Bundle. J Endourol. 2016 06; 30(6):709-13.
    View in: PubMed
    Score: 0.005
  55. Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer. Clin Genitourin Cancer. 2016 Feb; 14(1):e1-8.
    View in: PubMed
    Score: 0.004
  56. Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study. BMC Urol. 2015 Aug 01; 15:79.
    View in: PubMed
    Score: 0.004
  57. Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States. Urol Oncol. 2015 Nov; 33(11):496.e11-6.
    View in: PubMed
    Score: 0.004
  58. Regional Cost Variations of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy. Clin Genitourin Cancer. 2015 Oct; 13(5):447-52.
    View in: PubMed
    Score: 0.004
  59. Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma. J Urol. 2015 Nov; 194(5):1441-8.
    View in: PubMed
    Score: 0.004
  60. Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study. J Urol. 2013 Aug; 190(2):527-34.
    View in: PubMed
    Score: 0.004
  61. Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination. Prostate. 2011 Mar 01; 71(4):394-402.
    View in: PubMed
    Score: 0.003
  62. Reconstruction of late-onset transplant ureteral stricture disease. BJU Int. 2011 Mar; 107(6):982-7.
    View in: PubMed
    Score: 0.003
  63. Secondary infections of thoracic and abdominal aortic endografts. J Vasc Interv Radiol. 2009 Feb; 20(2):173-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.